Détention brevets de la classe A61K 31/664

Brevets de cette classe: 373

Historique des publications depuis 10 ans

38
25
29
38
23
32
29
27
23
21
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Ascentawits Pharmaceuticals, Ltd.
80
24
Pharmacyclics LLC
242
13
Royalty Security, LLC
20
10
The Johns Hopkins University
5913
9
Indaptus Therapeutics, Inc.
13
6
Gilead Sciences, Inc.
2236
5
Kite Pharma, Inc.
451
5
The United States of America, as represented by the Secretary, Department of Health and Human Services
3010
5
Immunogenesis, Inc.
20
5
Wuhan Neurophth Biotechnology Limited Company
19
5
Ascletis Pharma (China) Co., Limited
28
5
Merck Sharp & Dohme Corp.
2183
4
Alla Chem, LLC
49
4
Janssen Biotech, Inc.
1782
4
OBI Pharma, Inc.
128
4
Tufts Medical Center, Inc.
236
4
Yale University
2557
4
Eisai R&D Management Co., Ltd.
1167
4
IVACHTCHENKO, Alena Alexandrovna
14
4
The Regents of the University of California
20815
3
Autres propriétaires 246